Bersaldegenin-1,3,5-orthoacetate induces caspase-independent cell death, DNA damage and cell cycle arrest in human cervical cancer HeLa cells

References

• Adamska A, Stefanowicz-Hajduk J, Ochocka JR. 2019. Alpha-hederin, the active saponin of Nigella sativa, as an anticancer agent inducing apoptosis in the SKOV-3 cell line. Molecules. 24:2958.
   PubMed Web of Science ®Google Scholar
• Baek SH, Kim C, Lee JH, Nam D, Lee J, Lee SG, Chung WS, Jang HJ, Kim SH, Ahn KS. 2015. Cinobufagin exerts anti-proliferative and pro-apoptotic effects through the modulation ROS-mediated MAPKs signaling pathway. Immunopharmacol Immunotoxicol. 37:265–273.
   PubMed Web of Science ®Google Scholar
• Berges R, Denicolai E, Tchoghandjian A, Baeza-Kallee N, Honore S, Figarella-Branger D, Braguer D. 2018. Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma. Cell Death Dis. 9:984
   PubMed Web of Science ®Google Scholar
• Botha CJ, Kellerman TS, Anitra Schultz R, Erasmus G, Vleggaar R, Retief E. 1998. Krimpsiekte in a sheep following a single dose of Tylecodon ventricosus (Burm. f.) Toelken and the isolation of tyledoside D from this plant species. Onderstepoort J Vet Res. 65:17–23.
   PubMed Web of Science ®Google Scholar
• Chiao PJ, Miyamoto S, Verma IM. 1994. Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci U S A. 91:28–32.
   PubMed Web of Science ®Google Scholar
• Cunha Filho GA, Schwartz CA, Resck I, Murta MM, Lemos SS, Castro MS, Kyaw C, Pires ORJ, Leite JR, Bloch CJ, et al. 2005. Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens. Toxicon. 45:777–782.
   PubMed Web of Science ®Google Scholar
• Deng LJ, Qi M, Peng QL, Chen MF, Qi Q, Zhang JY, Yao N, Huang MH, Li XB, Peng YH, et al. 2018. Arenobufagin induces MCF-7 cell apoptosis by promoting JNK-mediated multisite phosphorylation of Yes-associated protein. Cancer Cell Int. 18:209.
   PubMed Web of Science ®Google Scholar
• Gao H, Popescu R, Kopp B, Wang Z. 2011. Bufadienolides and their antitumor activity. Nat Prod Rep. 28:953–969.
   PubMed Web of Science ®Google Scholar
• Goel A, Ram VJ. 2009. Natural and synthetic 2H-pyran-2-ones and their versatility in organic synthesis. Tetrahedron. 65:7865–7913.
   Web of Science ®Google Scholar
• Han L, Wang H, Si N, Ren W, Gao B, Li Y, Jian Y, Xu M, Zhao H, Bian B. 2016. Metabolites profiling of 10 bufadienolides in human liver microsomes and their cytotoxicity variation in HepG2 cell. Anal Bioanal Chem. 408:2485–2495.
   PubMed Web of Science ®Google Scholar
• Han L, Yuan B, Shimada R, Hayashi H, Si N, Zhao HY, Bian B, Takagi N. 2018. Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87. Int J Oncol. 53:2488–2502.
   PubMed Web of Science ®Google Scholar
• Huang HC, Lin MK, Yang HL, Hseu YC, Liaw CC, Tseng YH, Tsuzuki M, Kuo YH. 2013. Cardenolides and bufadienolide glycosides from Kalanchoe tubiflora and evaluation of cytotoxicity. Planta Med. 79:1362–1369.
   PubMed Web of Science ®Google Scholar
• Iguchi T, Yokosuka A, Kawahata R, Andou M, Mimaki Y. 2020. Bufadienolides from the whole plants of Helleborus foetidus and their cytotoxicity. Phytochemistry. 172:112277.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Bartek J. 2009. The DNA-damage response in human biology and disease. Nature. 461:1071–1078.
   PubMed Web of Science ®Google Scholar
• Johnson T. 1999. CRC Ethnobotany Desk Reference. Boca Raton (FL): CRC Press LLC.
   Google Scholar
• Kamboj A, Rathour A, Kaur M. 2013. Bufadienolides and their medicinal utility: a review. Int J Pharm Pharm Sci. 5:20–27.
   Google Scholar
• Kolodziejczyk-Czepas J, Nowak P, Wachowicz B, Piechocka J, Głowacki R, Moniuszko-Szajwaj B, Stochmal A. 2016. Antioxidant efficacy of Kalanchoe daigremontiana bufadienolide-rich fraction in blood plasma in vitro. Pharm Biol. 54:3182–3188.
   PubMed Web of Science ®Google Scholar
• Kolodziejczyk-Czepas J, Stochmal A. 2017. Bufadienolides of Kalanchoe species: an overview of chemical structure, biological activity and prospects for pharmacological use. Phytochem Rev. 16:1155–1171.
   PubMed Web of Science ®Google Scholar
• Mannuss A, Trapp O, Puchta H. 2012. Gene regulation in response to DNA damage. Biochim Biophys Acta. 1819:154–165.
   PubMed Web of Science ®Google Scholar
• Matsukawa M, Akizawa T, Ohigashi M, Morris JF, Butler VPJ, Yoshioka M. 1997. A novel bufadienolide, marinosin, in the skin of the giant toad, Bufo marinus. Chem Pharm Bull (Tokyo). 45:249–254.
   PubMed Web of Science ®Google Scholar
• Melero CP, Medarde M, San Feliciano A. 2000. A short review on cardiotonic steroids and their aminoguanidine analogues. Molecules. 5:51–81.
   Web of Science ®Google Scholar
• Moniuszko-Szajwaj B, Pecio Ł, Kowalczyk M, Stochmal A. 2016. New bufadienolides isolated from the roots of Kalanchoe daigremontiana (Crassulaceae). Molecules. 21:243.
   PubMed Web of Science ®Google Scholar
• Morishita S, Shoji M, Oguni Y, Ito C, Noguchi K, Sakanashi M. 1992. Effects of “kyushin”, a drug containing toad venom, on experimental congestive heart failure in rabbits. Am J Chin Med. 20:83–89.
   PubMed Web of Science ®Google Scholar
• Pohl T, Koorbanally C, Crouch NR, Mulholland DA. 2001. Bufadienolides from Drimia robusta and Urginea altissima (Hyacinthaceae). Phytochemistry. 58:557–561.
   PubMed Web of Science ®Google Scholar
• Schoner W, Scheiner-Bobis G. 2007. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol. 293:509–536.
   PubMed Web of Science ®Google Scholar
• Stefanowicz-Hajduk J, Asztemborska M, Krauze-Baranowska M, Godlewska S, Gucwa M, Moniuszko-Szajwaj B, Stochmal A, Ochocka JR. 2020. Identification of flavonoids and bufadienolides and cytotoxic effects of Kalanchoe daigremontiana extracts on human cancer cell lines. Planta Med. 86:239–246.
   PubMed Web of Science ®Google Scholar
• Steyn PS, van Heerden FR, Vleggaar R, Anderson LAP. 1986. Bufadienolide glucosides of the Crassulaceae. J Chem Soc Perkin Trans. 1:1633–1636.
   Google Scholar
• Stoll A, Suter E, Kreis W, Bussemaker BB, Hofmann A. 1933. Die herzaktiven Substanzen der Meerzwiebel. Scillaren A. Helv Chim Acta. 16:70.
   Google Scholar
• Sun SC, Ganchi PA, Ballard DW, Greene WC. 1993. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science. 259:1912–1915.
   PubMed Web of Science ®Google Scholar
• Supratman U, Fujita T, Akiyama K, Hayashi H, Murakami A, Sakai H, Koshimizu K, Ohigashi H. 2001. Anti-tumor promoting activity of bufadienolides from Kalanchoe pinnata and K. daigremontiana x tubiflora. Biosci Biotechnol Biochem. 65:947–949.
   PubMed Web of Science ®Google Scholar
• Tian HY, Wang L, Zhang XQ, Wang Y, Zhang DM, Jiang RW, Liu Z, Liu JS, Li YL, Ye WC. 2010. Bufogargarizins A and B: two novel 19-norbufadienolides with unprecedented skeletons from the venom of Bufo bufo gargarizans. Chemistry. 16:10989–10993.
   PubMed Web of Science ®Google Scholar
• Uasnova IV, Khushbaktova ZA, Syrov VN, Azizov DE, Mirzaakhmedov S, Soliev AB, Tashmukhamedov MS, Salikhov S. 2002. Cardiotonic activity of total bufadienolides from the poison of Central Asian toad Bufo viridis. Eksp Klin Farmakol. 65:23–27.
   Google Scholar
• Wagner H, Fischer M, Lotter H. 1985. Isolation and structure determination of daigremontianin, a novel bufadienolide from Kalanchoe daigremontiana. Planta Med. 51:169–171.
   Web of Science ®Google Scholar
• Wang W, Mani AM, Wu ZH. 2017. DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression. J Cancer Metastasis Treat. 3:45–59.
   PubMedGoogle Scholar
• Watanabe K, Mimaki Y, Sakagami H, Sashida Y. 2003. Bufadienolide and spirostanol glycosides from the rhizomes of helleborusorientalis. J Nat Prod. 66:236–241.
   PubMed Web of Science ®Google Scholar
• Wu PL, Hsu YL, Wu TS, Bastow KF, Lee KH. 2006. Kalanchosides A-C, new cytotoxic bufadienolides from the aerial parts of Kalanchoe gracilis. Org Lett. 8:5207–5210.
   PubMed Web of Science ®Google Scholar
• Wu SH, Bau DT, Hsiao YT, Lu KW, Hsia TC, Lien JC, Ko YC, Hsu WH, Yang ST, Huang YP, et al. 2017. Bufalin induces apoptosis in vitro and has antitumor activity against human lung cancer xenografts in vivo. Environ Toxicol. 32:1305–1317.
   PubMed Web of Science ®Google Scholar
• Yamagishi T, Haruna M, Yan XZ, Chang JJ, Lee KH. 1989. Antitumor agents, 110. Bryophyllin B, a novel potent cytotoxic bufadienolide from Bryophyllum pinnatum. J Nat Prod. 52:1071–1079.
   PubMed Web of Science ®Google Scholar
• Yeh JY, Huang WJ, Kan SF, Wang PS. 2003. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate. 54:112–124.
   PubMed Web of Science ®Google Scholar
• Yuan B, Shimada R, Xu K, Han L, Si N, Zhao H, Bian B, Hayashi H, Okazaki M, Takagi N. 2019. Multiple cytotoxic effects of gamabufotalin against human glioblastoma cell line U-87. Chem Biol Interact. 314:108849.
   PubMed Web of Science ®Google Scholar
• Zhang G, Wang C, Sun M, Li J, Wang B, Jin C, Hua P, Song G, Zhang Y, Nguyen LLH, et al. 2016. Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells. Oncotarget. 7:28935–28946.
   PubMedGoogle Scholar
• Zhu L, Chen Y, Wei C, Yang X, Cheng J, Yang Z, Chen C, Ji Z. 2018. Anti-proliferative and pro-apoptotic effects of cinobufagin on human breast cancer MCF-7 cells and its molecular mechanism. Nat Prod Res. 32:493–497.
   PubMed Web of Science ®Google Scholar